Trygg Pharma AS – a company that will be jointly owned by Aker BioMarine ASA and an affiliate of Lindsay Goldberg LLC through a newly established joint venture company (cf. the separate notice of today) – has entered into an agreement to acquire 100% of the shares in Epax Holding AS (together with its subsidiaries “Epax”), a wholly owned subsidiary of Austevoll Seafood ASA. Epax is the world’s premier high concentrate omega-3 supplement manufacturer. Epax employs a total of 74 people.
In July 2013, FMC Corporation acquired Epax Nutra Holding III AS (Norway) and Epax UK Holding III AS (United Kingdom) (together, Epax)
Fisherman's Day: Beyond the Ritual Peru
Every June 29th, as tomorrow, Peru fervently celebrates Saint Peter's Day and —in honor of his profession— Fisherman's Day. This deeply symbolic date combines religious devotion to the apo...
Vietnam's Tuna Exports Rebound in May 2025 Amid Global Trade Shifts Viet Nam
Producers Navigate US Tax Concerns and Middle East Instability by Diversifying Markets.
HANOI – After facing headwinds in early 2025, Vietnam's tuna exports saw a significant recovery in May, r...
Trygg Pharma AS
Personal Profile
Shareholder companies:
Print
